Subjects with NAFLD had a significantly higher body mass index (BMI) and serum levels of fasting glucose, glycosylated hemoglobin (HbA1c), alanine aminotransferase (ALT), aspartate transaminase (AST), triglyceride (TG), fasting insulin, and homeostasis model assessment of insulin resistance (HOMA-IR), compared to those without NAFLD. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.